Search hospitals > Arkansas > Hot Springs National Park
Genesis Cancer Center
Claim this profileHot Springs National Park, Arkansas 71913
Global Leader in Lung Cancer
Global Leader in Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Cancer
Conducts research for Small Cell Lung Cancer
58 reported clinical trials
4 medical researchers
Summary
Genesis Cancer Center is a medical facility located in Hot Springs National Park, Arkansas. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Cancer, Small Cell Lung Cancer and other specialties. Genesis Cancer Center is involved with conducting 58 clinical trials across 79 conditions. There are 4 research doctors associated with this hospital, such as Stephen (Fred) G Divers, Roy Webb, MD, Robert T Muldoon, MD, and Stephen Divers.Area of expertise
1Lung Cancer
Global LeaderStage III
PD-L1 positive
PD-L1 negative
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
Top PIs
Stephen (Fred) G DiversGenesis Cancer Center2 years of reported clinical research
Studies Breast Cancer
Studies Cytochrome P450
3 reported clinical trials
4 drugs studied
Roy Webb, MDGenesis Cancer Center6 years of reported clinical research
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
5 drugs studied
Robert T Muldoon, MDGenesis Cancer and Blood Institute1 year of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
1 reported clinical trial
1 drug studied
Stephen DiversGenesis Cancer and Blood Institute2 years of reported clinical research
Studies Cytochrome P450
Studies Allergy
1 reported clinical trial
2 drugs studied
Clinical Trials running at Genesis Cancer Center
Breast Cancer
PD-L1 Negative
Programmed Death-Ligand 1 Positive
Stomach Cancer
Ovarian Cancer
Colorectal Cancer
Cancer
Hepatocellular Carcinoma
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
This trial compares the effectiveness of a combination of two drugs, SG and pembrolizumab, in patients with advanced triple-negative breast cancer. SG targets and kills cancer cells with chemotherapy, while pembrolizumab helps the immune system attack the cancer. Pembrolizumab has been shown to improve survival in various cancers, including triple-negative breast cancer, when used alone or in combination with other treatments.
Recruiting4 awards Phase 3
Giredestrant + Phesgo
for Breast Cancer
This trial is testing whether a combination of two drugs is more effective than one drug for patients with advanced breast cancer. The drugs work by blocking signals that help cancer cells grow. The study focuses on patients whose cancer cannot be cured with surgery or other local treatments.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Genesis Cancer Center?
Genesis Cancer Center is a medical facility located in Hot Springs National Park, Arkansas. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Cancer, Small Cell Lung Cancer and other specialties. Genesis Cancer Center is involved with conducting 58 clinical trials across 79 conditions. There are 4 research doctors associated with this hospital, such as Stephen (Fred) G Divers, Roy Webb, MD, Robert T Muldoon, MD, and Stephen Divers.